Immunome Inc
NASDAQ:IMNM

Watchlist Manager
Immunome Inc Logo
Immunome Inc
NASDAQ:IMNM
Watchlist
Price: 21.71 USD -2.78% Market Closed
Market Cap: 2B USD

Wall Street
Price Targets

IMNM Price Targets Summary
Immunome Inc

Wall Street analysts forecast IMNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMNM is 34.94 USD with a low forecast of 26.26 USD and a high forecast of 42 USD.

Lowest
Price Target
26.26 USD
21% Upside
Average
Price Target
34.94 USD
61% Upside
Highest
Price Target
42 USD
93% Upside
Immunome Inc Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
36% Upside
300676
BGI Genomics Co Ltd
28% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
RPTX
Repare Therapeutics Inc
19% Upside
CAPR
Capricor Therapeutics Inc
75% Upside
2256
Abbisko Cayman Ltd
79% Upside
ORKA
Oruka Therapeutics Inc
58% Upside

Revenue
Forecast

Revenue Estimate
Immunome Inc

The compound annual growth rate of Immunome Inc's revenue for the next 4 years is 110%.

N/A
Past Growth
110%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMNM's stock price target?
Price Target
34.94 USD

According to Wall Street analysts, the average 1-year price target for IMNM is 34.94 USD with a low forecast of 26.26 USD and a high forecast of 42 USD.

What is Immunome Inc's Revenue forecast?
Projected CAGR
110%

The compound annual growth rate of Immunome Inc's revenue for the next 4 years is 110%.

Back to Top